MedPath

Quercis Pharma AG

Quercis Pharma AG logo
🇨🇭Switzerland
Ownership
Holding
Established
2019-01-01
Employees
11
Market Cap
-
Website
http://www.quercis.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

The Effect of Isoquercetin on Thromboembolic Events in Patients with Metastatic Pancreatic Cancer

Phase 3
Not yet recruiting
Conditions
Venous Thromboembolism
Metastatic Pancreatic Cancer
Interventions
Drug: Placebo
First Posted Date
2025-03-06
Last Posted Date
2025-03-06
Lead Sponsor
Quercis Pharma AG
Target Recruit Count
340
Registration Number
NCT06861088

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.